Showing 20 of 40 recruiting trials for “pauci-immune-glomerulonephritis-with-anca”
PS-002 for the Treatment of IgA Nephropathy in Adults
Phase Ⅲ Study of Efficacy and Safety of HSK39297 Tablet in Treatment of Patients With Primary IgAN
Study to Assess the Efficacy, Pharmacokinetics, Safety and Tolerability of Iptacopan in Pediatric Patients With Primary IgAN
A Phase IIa Clinical Study of RG002C0106 Injection in Subjects With Primary IgA Nephropathy
🏥 Rigerna Therapeutics Co., Ltd.; Rigerna Therapeutics (Beijing) Co., Ltd.📍 1 site📅 Started Sep 2025View details ↗
Nefecon and Ambrisentan in IgA Nephropathy
Phase 2 Study of ADX-038 in Complement-Mediated Kidney Disease
A Study of Cizutamig in Patients With Immunoglobulin A Nephropathy
A Study of Mezagitamab in Adults With Primary IgA Nephropathy Kidney Condition
Atacicept in Multiple Glomerular Diseases
Identification and Characterisation of IgA With Nephritogenic Potential in IgA Deposition Nephropathies (Rep-IgAN)
RecruitingNCT06926244 ↗
RESistance of IgA Nephropathy to Conventional and Newly-approved Therapies: an Observational, Real-life Study (RESIGAN)
Avacopan in Crescentic Immunoglobulin A Nephropathy (IgAN)
A Trial of HRS-5965 Capsule in Primary IgA Nephropathy
Monthly Dosing of Atacicept in IgAN
Finerenone in Patients With IgA-nephropathy: Prospective Interventional Trial
A Study to Learn About the Effects of Felzartamab Infusions on Adults With Immunoglobulin A Nephropathy (IgAN)
RecruitingNCT06952426 ↗
A Mobile App-Based Study to Evaluate Disease Burden and Treatment Patterns in Immunoglobulin A Nephropathy (IgAN) in the US
A Study of SC0062 Capsule for the Treatment of IgA Nephropathy with Proteinuria
Efficacy and Safety of Extended TARPEYO® Treatment Beyond 9 Months in Adult Patients With Primary IgA Nephropathy
Efficacy and Safety of Telitacicept in IgAN
Page 1 of 2Next →
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →